Delivery Order SPE2DB22D1106-SPE2DB25FFBC9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with a ceiling value of $1,179.45 and a firm fixed price structure. This delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.16 to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 mL (5 mL vials) on July 30, 2025, with completion scheduled for July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,289.37 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL vials, with an ultimate completion date of July 30, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,218.01 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL units. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, was awarded competitively with no set-aside designation and represents a child contract under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,979.20, is for the delivery of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a $10,795.82 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product, with an ultimate completion date of June 18, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Betamethasone SP-AC 30 mg/5 ml 5 ml medication. The contract has a firm fixed price of $1,174.93 and a period of performance through April 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of BETAMETHASONE SP-AC 30 MG/5 ML 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $3,530.66 and a completion date of June 9, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract is not a set-aside and was awarded on June 6, 2025. Additionally, Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,798.55 firm fixed-price delivery order is for the supply of Betamethasone SP-AC 30 MG/5 ML 5ML, a medical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,502.96 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBC9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL quantities, with a ceiling value of $4,992.01. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The contract utilizes no set-aside designation, indicating it was awarded through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp has demonstrated consistent capability to meet federal procurement requirements through open competition, with its contract portfolio encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains for customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/1/25 |